Data from Antitumor Synergism and Enhanced Survival with a Tumor Vasculature–Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide

MLA

Roger G. Harrison, et al. Data from Antitumor Synergism and Enhanced Survival with a Tumor Vasculature–Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.c.6538777.

APA

Roger G. Harrison, Carla Kurkjian, Vassilios I. Sikavitsas, Kar-Ming Fung, Quang Nguyen, Patrick H. McKernan, Needa Virani, & John J. Krais. (2023). Data from Antitumor Synergism and Enhanced Survival with a Tumor Vasculature–Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide. https://doi.org/10.1158/1535-7163.c.6538777

Chicago

Roger G. Harrison, Carla Kurkjian, Vassilios I. Sikavitsas, Kar-Ming Fung, Quang Nguyen, Patrick H. McKernan, Needa Virani, and John J. Krais. 2023. “Data from Antitumor Synergism and Enhanced Survival with a Tumor Vasculature–Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide,” April. doi:10.1158/1535-7163.c.6538777.